Company profile: Wellinq
1.1 - Company Overview
Company description
- Provider of minimal invasive vascular solutions and medical devices, offering contract development and manufacturing with regulatory registrations and clinical guidance. Products include angiographic catheters (Pointer), hydrophilic-coated guiding catheters for transradial percutaneous coronary interventions (Primum), and semi-finished catheter components for customization and local assembly. Also produces sensors via Sentron for medical and general industry markets.
Products and services
- Contract Manufacturing: Wellinq fabricates and scales product lines, managing regulatory registrations and assuming full product responsibility for branded and OEM products
- Regulatory-grade service enabling rapid launches or expansions
- Guiding Catheter Primum: Hydrophilic-coated guiding catheter used in transradial percutaneous coronary interventions, known for procedural success and safety
- Interventional-grade device for minimally invasive vascular access
- Angiographic Catheter Pointer: Angiographic catheter with hydrodynamic surface for low friction, double wire stainless steel braiding for kink resistance, and a soft tip to minimize vessel damage
- Precision-grade construction
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Wellinq
Nemcomed
HQ: United States
Website
- Description: Provider of precision-machined tools and implants for surgical and medical specialties, offering design, manufacturing, and delivery capabilities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nemcomed company profile →
Riester
HQ: United States
Website
- Description: Provider of diagnostic instruments and devices designed to meet top requirements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Riester company profile →
Covidien
HQ: Ireland
Website
- Description: Provider of healthcare products developed, manufactured and sold for clinical and home settings, operating through four segments including Medical Devices covering endomechanical instruments, soft tissue repair products, energy devices, and oximetry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Covidien company profile →
i-Lumen
HQ: United States
Website
- Description: Provider of a non-invasive, software-based medical device (i-LUMEN System and Therapy) delivering pulsed microcurrent stimulation to treat dry age-related macular degeneration, and of clinical trials (i-SIGHT Clinical Study) for the i-LUMEN AMD device in patients with nonexudative (dry) AMD in the United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full i-Lumen company profile →
Bard EP
HQ: United States
Website
- Description: Provider of innovative healthcare products and services focused on disease state management in vascular, urology, and oncology, serving the needs of healthcare providers and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bard EP company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Wellinq
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Wellinq
2.2 - Growth funds investing in similar companies to Wellinq
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Wellinq
4.2 - Public trading comparable groups for Wellinq
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →